TaiMed Biologics
About:
TaiMed Biologics is a biotechnology company that develops monoclonal antibody therapeutics for HIV disease.
Website: http://www.taimedbiologics.com
Top Investors: YFY Biotech Management Company, Taiwan Development Fund
Description:
TaiMed Biologics is a biopharmaceutical developer and manufacturer. They develop antibodies and small molecules for the treatment and prevention of HIV infections. They offer contract development and manufacturing organization services for biopharmaceutical companies.
Total Funding Amount:
$22M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Taipei, T'ai-pei, Taiwan
Founded Date:
2007-09-04
Contact Email:
jackchen(AT)taimedbiologics.com
Founders:
David Ho, Ing-Wen Tsai, LanBo Chen
Number of Employees:
51-100
Last Funding Date:
2010-03-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai